13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q1 2025. See the latest, Q2 2026 →

Reported value

$459.90B

−5.4% on the quarter before

Positions

456

39 new · 21 sold out

Top 10

31.2%

of the value

Est. gain

−$12.94B

on stocks held all quarter

Est. return

−3.0%

on those stocks since Q4 2024

Filed

May 12, 2025

On SEC EDGAR ↗

Positions as of Mar 31, 2025, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.

Microsoft6.1%Meta4.3%Amazon3.6%Broadcom3.3%Eli Lilly2.8%
Unitedhealth Group Inc2.4%
Apple2.3%Nvidia2.3%
Rtx Corporation2.2%
Uber1.9%Alphabet1.8%
Philip Morris Intl Inc1.5%
Vertex Pharmaceuticals Inc1.5%
Abbvie Inc1.5%
Boeing Co1.5%
Ge Aerospace1.5%
Abbott Labs1.5%
Gilead Sciences Inc1.3%
Alphabet1.2%Mastercard1.2%Salesforce1.2%
Jpmorgan Chase & Co.1.1%
Carrier Global1.1%
Royal Caribbean Group1.0%

Largest buys

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Eli Lilly~$4.12BAdded · 1.7% → 2.8%+4,989,952 shares
  2. Nvidia~$3.51BAdded · 1.8% → 2.3%+32,380,763 shares
  3. Starbucks Corp~$2.92BAdded · 0.1% → 0.8%+29,731,895 shares
  4. Vertex Pharmaceuticals Inc~$1.99BAdded · 0.9% → 1.5%+4,107,393 shares
  5. Unitedhealth Group Inc~$1.50BAdded · 1.9% → 2.4%+2,860,632 shares
  6. Stellantis N.V~$1.15BAdded · 0.0% → 0.3%+102,364,988 shares
  7. Cvs Health Corp~$1.10BAdded · 0.0% → 0.3%+16,220,891 shares
  8. Marsh & Mclennan Cos Inc~$1.02BAdded · 0.1% → 0.3%+4,160,208 shares
  9. Oracle~$986.5MAdded · 0.4% → 0.6%+7,055,779 shares
  10. Microstrategy Inc~$758.8MAdded · 0.0% → 0.2%+2,632,421 shares

Largest sells

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Apple~$5.28BCut · 3.7% → 2.3%−23,748,072 shares
  2. Alphabet~$2.80BCut · 2.8% → 1.8%−18,112,901 shares
  3. Ge Aerospace~$1.60BCut · 1.4% → 1.5%−8,004,055 shares
  4. Meta~$1.49BCut · 4.4% → 4.3%−2,580,399 shares
  5. Pnc Finl Svcs Group Inc~$1.34BCut · 0.4% → 0.1%−7,644,593 shares
  6. Las Vegas Sands Corp~$1.22BCut · 0.6% → 0.2%−31,592,047 shares
  7. Danaher Corporation~$1.01BCut · 0.3% → 0.0%−4,940,823 shares
  8. Royal Caribbean Group~$1.01BCut · 1.3% → 1.0%−4,903,316 shares
  9. Philip Morris Intl Inc~$945.3MCut · 1.3% → 1.5%−5,955,282 shares
  10. Capital One Finl Corp~$928.7MCut · 0.4% → 0.3%−5,179,622 shares

Holdings

As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares −0.4% · price −10.9%6.1%$28.11B−$3.45B
MetaCL A · shares −7.0% · price −1.6%4.3%$19.78B−$314.2M
AmazonCOM · shares −3.3% · price −13.3%3.6%$16.34B−$2.50B
BroadcomCOM · shares −0.2% · price −27.8%3.3%$14.98B−$5.76B
Eli LillyCOM · shares +46% · price +7.0%2.8%$13.01B+$579.9M
Unitedhealth Group IncCOM · shares +16% · price +3.5%2.4%$10.91B+$321.4M
AppleCOM · shares −33% · price −11.3%2.3%$10.76B−$1.37B
NvidiaCOM · shares +51% · price −19.3%2.3%$10.43B−$1.66B
Rtx CorporationCOM · shares +2.7% · price +14.5%2.2%$10.31B+$1.27B
UberCOM · shares +1.6% · price +20.8%1.9%$8.75B+$1.48B
AlphabetCAP STK CL A · shares −25% · price −18.3%1.8%$8.34B−$1.87B
Philip Morris Intl IncCOM · shares −12% · price +31.9%1.5%$7.13B+$1.72B
Vertex Pharmaceuticals IncCOM · shares +39% · price +20.4%1.5%$7.05B+$856.5M
Abbvie IncCOM · shares −1.4% · price +17.9%1.5%$7.02B+$1.07B
Boeing CoCOM · shares +3.4% · price −3.6%1.5%$6.82B−$249.4M
Ge AerospaceCOM NEW · shares −19% · price +20.0%1.5%$6.80B+$1.13B
Abbott LabsCOM · shares −6.2% · price +17.3%1.5%$6.73B+$991.3M
Gilead Sciences IncCOM · shares −5.8% · price +21.3%1.3%$6.12B+$1.07B
AlphabetCAP STK CL C · shares −7.5% · price −18.0%1.2%$5.66B−$1.24B
MastercardCL A · shares −0.2% · price +4.1%1.2%$5.60B+$220.2M
SalesforceCOM · shares −14% · price −19.7%1.2%$5.58B−$1.37B
Jpmorgan Chase & Co.COM · shares −6.3% · price +2.3%1.1%$5.25B+$119.6M
Carrier GlobalCOM · shares +6.5% · price −7.1%1.1%$5.10B−$366.9M
Royal Caribbean GroupCOM · shares −17% · price −10.9%1.0%$4.79B−$589.1M
Home Depot IncCOM · shares −3.9% · price −5.8%0.95%$4.39B−$269.4M
Total · 456 positions100%$459.90B−$12.94B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2024 to Q1 2025: 416 stocks held throughout, down $12.94B (−3.0%).

  1. Philip Morris Intl Inc+$1.72B+32%
  2. Uber+$1.48B+21%
  3. Rtx Corporation+$1.27B+14%
  4. Ge Aerospace+$1.13B+20%
  5. Gilead Sciences Inc+$1.07B+21%
  6. Nvidia−$1.66B−19%
  7. Alphabet−$1.87B−18%
  8. Amazon−$2.50B−13%
  9. Microsoft−$3.45B−11%
  10. Broadcom−$5.76B−28%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.